Equities
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,124.50
  • Today's Change30.00 / 1.43%
  • Shares traded3.85m
  • 1 Year change-9.60%
  • Beta0.7622
Data delayed at least 20 minutes, as of Nov 25 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments573,851563,355465,177
Total Receivables, Net122,830109,842123,016
Total Inventory64,91657,91945,892
Prepaid expenses------
Other current assets, total22,60853,07625,120
Total current assets784,205784,192659,205
Property, plant & equipment, net124,026118,567112,417
Goodwill, net15,2879,8199,638
Intangibles, net117,62196,30981,223
Long term investments320,089274,093269,151
Note receivable - long term------
Other long term assets42,1646,7206,060
Total assets1,416,9181,311,8001,150,601
LIABILITIES
Accounts payable14,80814,00516,372
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases2,8673,0142,945
Other current liabilities, total116,232141,533105,079
Total current liabilities133,907158,552124,396
Total long term debt8,7536,3973,729
Total debt11,6209,4116,674
Deferred income tax4,3605,9167,807
Minority interest17,23621,83217,624
Other liabilities, total17,33619,05721,384
Total liabilities181,592211,754174,940
SHAREHOLDERS EQUITY
Common stock21,27921,27921,279
Additional paid-in capital14,24215,20414,455
Retained earnings (accumulated deficit)1,065,913940,606832,958
Treasury stock - common(137889)(63074)(57857)
Unrealized gain (loss)--1.00--
Other equity, total271,781186,030164,826
Total equity1,235,3261,100,046975,661
Total liabilities & shareholders' equity1,416,9181,311,8001,150,601
Total common shares outstanding850883904
Treasury shares - common primary issue723930
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.